Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

1.

Genetic Modulation of Neurocognitive Function in Glioma Patients.

Liu Y, Zhou R, Sulman EP, Scheurer ME, Boehling N, Armstrong G, Tsavachidis S, Liang FW, Etzel CJ, Conrad CA, Gilbert MR, Armstrong TS, Bondy ML, Wefel J.

Clin Cancer Res. 2015 Apr 22. pii: clincanres.0168.2015. [Epub ahead of print]

PMID:
25904748
2.

Bayesian hierarchical structured variable selection methods with application to MIP studies in breast cancer.

Zhang L, Baladandayuthapani V, Mallick BK, Manyam GC, Thompson PA, Bondy ML, Do KA.

J R Stat Soc Ser C Appl Stat. 2014 Aug;63(4):595-620.

PMID:
25705056
3.

Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the Gliogene Consortium.

Jalali A, Amirian ES, Bainbridge MN, Armstrong GN, Liu Y, Tsavachidis S, Jhangiani SN, Plon SE, Lau CC, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston RS, Jenkins RB, Lachance D, Olson SH, Bernstein JL, Merrell RT, Wrensch MR, Davis FG, Lai R, Shete S, Aldape K, Amos CI, Muzny DM, Gibbs RA, Melin BS, Bondy ML.

Sci Rep. 2015 Feb 5;5:8278. doi: 10.1038/srep08278.

4.

Survival and low-grade glioma: the emergence of genetic information.

Claus EB, Walsh KM, Wiencke JK, Molinaro AM, Wiemels JL, Schildkraut JM, Bondy ML, Berger M, Jenkins R, Wrensch M.

Neurosurg Focus. 2015 Jan;38(1):E6. doi: 10.3171/2014.10.FOCUS12367.

PMID:
25552286
5.

Germline mutations in shelterin complex genes are associated with familial glioma.

Bainbridge MN, Armstrong GN, Gramatges MM, Bertuch AA, Jhangiani SN, Doddapaneni H, Lewis L, Tombrello J, Tsavachidis S, Liu Y, Jalali A, Plon SE, Lau CC, Parsons DW, Claus EB, Barnholtz-Sloan J, Il'yasova D, Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston RS, Jenkins RB, Lachance D, Olson SH, Bernstein JL, Merrell RT, Wrensch MR, Walsh KM, Davis FG, Lai R, Shete S, Aldape K, Amos CI, Thompson PA, Muzny DM, Gibbs RA, Melin BS, Bondy ML; Gliogene Consortium.

J Natl Cancer Inst. 2014 Dec 7;107(1):384. doi: 10.1093/jnci/dju384. Print 2015 Jan.

PMID:
25482530
6.

Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival.

Pande M, Bondy ML, Do KA, Sahin AA, Ying J, Mills GB, Thompson PA, Brewster AM.

Breast Cancer Res Treat. 2014 Sep;147(2):381-7. doi: 10.1007/s10549-014-3081-9. Epub 2014 Aug 10.

PMID:
25108739
7.

A pooled multisite analysis of the effects of female reproductive hormones on glioma risk.

Krishnamachari B, Il'yasova D, Scheurer ME, Bondy ML, Wrensch M, Davis FG.

Cancer Causes Control. 2014 Aug;25(8):1007-13. doi: 10.1007/s10552-014-0400-8. Epub 2014 Jun 3.

8.

Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancer.

Thompson PA, Ljuslinder I, Tsavachidis S, Brewster A, Sahin A, Hedman H, Henriksson R, Bondy ML, Melin BS.

Cancer Res. 2014 Jun 1;74(11):2928-35. doi: 10.1158/0008-5472.CAN-13-2112.

PMID:
24879564
9.

Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.

Andersson U, Wibom C, Cederquist K, Aradottir S, Borg A, Armstrong GN, Shete S, Lau CC, Bainbridge MN, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Houlston RS, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Lachance DH, Wrensch M, Davis FG, Merrell R, Johansen C, Sadetzki S; Gliogene Consortium, Bondy ML, Melin BS.

Neuro Oncol. 2014 Oct;16(10):1333-40. doi: 10.1093/neuonc/nou052. Epub 2014 Apr 9.

10.

Endogenous and exogenous hormone exposure and the risk of meningioma in men.

Schildkraut JM, Calvocoressi L, Wang F, Wrensch M, Bondy ML, Wiemels JL, Claus EB.

J Neurosurg. 2014 Apr;120(4):820-6. doi: 10.3171/2013.12.JNS131170. Epub 2014 Jan 31.

11.

Presence of viral DNA in whole-genome sequencing of brain tumor tissues from the cancer genome atlas.

Amirian ES, Bondy ML, Mo Q, Bainbridge MN, Scheurer ME.

J Virol. 2014 Jan;88(1):774. doi: 10.1128/JVI.02725-13. No abstract available.

12.

Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer.

Liu Y, Zhou R, Baumbusch LO, Tsavachidis S, Brewster AM, Do KA, Sahin A, Hortobagyi GN, Taube JH, Mani SA, Aarøe J, Wärnberg F, Børresen-Dale AL, Mills GB, Thompson PA, Bondy ML.

Breast Cancer Res Treat. 2014 Jan;143(1):189-201. doi: 10.1007/s10549-013-2796-3. Epub 2013 Dec 4.

13.

Anti-human-cytomegalovirus immunoglobulin G levels in glioma risk and prognosis.

Amirian ES, Marquez-Do D, Bondy ML, Scheurer ME.

Cancer Med. 2013 Feb;2(1):57-62. doi: 10.1002/cam4.44. Epub 2013 Feb 3.

14.

Antihistamine use and immunoglobulin E levels in glioma risk and prognosis.

Amirian ES, Marquez-Do D, Bondy ML, Scheurer ME.

Cancer Epidemiol. 2013 Dec;37(6):908-12. doi: 10.1016/j.canep.2013.08.004. Epub 2013 Aug 30.

15.

Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer.

Chen JQ, Bao Y, Lee J, Murray JL, Litton JK, Xiao L, Zhou R, Wu Y, Shen XY, Zhang H, Sahin AA, Katz RL, Bondy ML, Berinstein NL, Hortobagyi GN, Radvanyi LG.

Ann Oncol. 2013 Oct;24(10):2534-42. doi: 10.1093/annonc/mdt190. Epub 2013 May 31.

16.

Integration of epidemiology, immunobiology, and translational research for brain tumors.

Okada H, Scheurer ME, Sarkar SN, Bondy ML.

Ann N Y Acad Sci. 2013 May;1284:17-23. doi: 10.1111/nyas.12115.

17.

The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.

Bayraktar S, Thompson PA, Yoo SY, Do KA, Sahin AA, Arun BK, Bondy ML, Brewster AM.

Oncologist. 2013;18(5):493-500. doi: 10.1634/theoncologist.2012-0419. Epub 2013 May 1.

18.

Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer.

Murray JL, Thompson P, Yoo SY, Do KA, Pande M, Zhou R, Liu Y, Sahin AA, Bondy ML, Brewster AM.

Breast Cancer Res Treat. 2013 Apr;138(3):917-24. doi: 10.1007/s10549-013-2445-x. Epub 2013 Mar 26.

19.

The Childhood Leukemia International Consortium.

Metayer C, Milne E, Clavel J, Infante-Rivard C, Petridou E, Taylor M, Schüz J, Spector LG, Dockerty JD, Magnani C, Pombo-de-Oliveira MS, Sinnett D, Murphy M, Roman E, Monge P, Ezzat S, Mueller BA, Scheurer ME, Armstrong BK, Birch J, Kaatsch P, Koifman S, Lightfoot T, Bhatti P, Bondy ML, Rudant J, O'Neill K, Miligi L, Dessypris N, Kang AY, Buffler PA.

Cancer Epidemiol. 2013 Jun;37(3):336-47. doi: 10.1016/j.canep.2012.12.011. Epub 2013 Feb 9.

20.

Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.

Sadetzki S, Bruchim R, Oberman B, Armstrong GN, Lau CC, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut J, Johansen C, Houlston RS, Shete S, Amos CI, Bernstein JL, Olson SH, Jenkins RB, Lachance D, Vick NA, Merrell R, Wrensch M, Davis FG, McCarthy BJ, Lai R, Melin BS, Bondy ML; Gliogene Consortium.

Eur J Cancer. 2013 Apr;49(6):1335-45. doi: 10.1016/j.ejca.2012.11.009. Epub 2013 Jan 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk